Medprin Regenerative Medical Technologies Co. Ltd. (301033) - Total Liabilities

Latest as of June 2025: CN¥88.79 Million CNY ≈ $12.99 Million USD

Based on the latest financial reports, Medprin Regenerative Medical Technologies Co. Ltd. (301033) has total liabilities worth CN¥88.79 Million CNY (≈ $12.99 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 301033 financial resilience to evaluate the company's liquid asset resilience ratio.

Medprin Regenerative Medical Technologies Co. Ltd. - Total Liabilities Trend (2019–2024)

This chart illustrates how Medprin Regenerative Medical Technologies Co. Ltd.'s total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see balance sheet size of Medprin Regenerative Medical Technologie.

Medprin Regenerative Medical Technologies Co. Ltd. Competitors by Total Liabilities

The table below lists competitors of Medprin Regenerative Medical Technologies Co. Ltd. ranked by their total liabilities.

Company	Country	Total Liabilities
GEOPARK LTD. DL -001 F:G6O	Germany	€794.65 Million
Bansal Wire Industries Ltd NSE:BANSALWIRE	India	Rs10.86 Billion
Anshan Senyuan Road Bridge SHE:300210	China	CN¥587.19 Million
Vishnu Chemicals Limited NSE:VISHNU	India	Rs10.13 Billion
Guangzhou Seagull Kitchen And Bath Products Co Ltd SHE:002084	China	CN¥1.44 Billion
Daou Data Corp KQ:032190	Korea	₩67.26 Trillion
TINC Comm VA BR:TINC	Belgium	€35.74 Million
MTY Food Group Inc TO:MTY	Canada	CA$1.67 Billion

Liability Composition Analysis (2019–2024)

This chart breaks down Medprin Regenerative Medical Technologies Co. Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Medprin Regenerative Medical Technologie net asset quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	7.23	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.12	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.11	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Medprin Regenerative Medical Technologies Co. Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Medprin Regenerative Medical Technologies Co. Ltd. (2019–2024)

The table below shows the annual total liabilities of Medprin Regenerative Medical Technologies Co. Ltd. from 2019 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥99.57 Million ≈ $14.57 Million	-34.11%
2023-12-31	CN¥151.11 Million ≈ $22.11 Million	+6.16%
2022-12-31	CN¥142.34 Million ≈ $20.83 Million	-16.72%
2021-12-31	CN¥170.92 Million ≈ $25.01 Million	+45.75%
2020-12-31	CN¥117.26 Million ≈ $17.16 Million	+214.62%
2019-12-31	CN¥37.27 Million ≈ $5.45 Million	--

About Medprin Regenerative Medical Technologies Co. Ltd.

SHE:301033 China Medical Devices

Market Cap

$525.70 Million

CN¥3.59 Billion CNY

Market Cap Rank

#12088 Global

#3505 in China

Share Price

CN¥53.58

Change (1 day)

+1.44%

52-Week Range

CN¥45.16 - CN¥81.00

All Time High

CN¥88.80